Kobo Biotech Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1993.
1993 Hyderabad, Telangana, India Under Cirp
Last Updated:
Access Report
About Kobo Biotech Limited

Kobo Biotech Limited, a under cirp public limited company, was established on 03 August 1993 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24110TG1993PLC016112. Registered under ROC Roc Hyderabad. it is listed on BSE: 531541. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹23.83 Cr.

Formerly known as Kobo Biotech Limited, Avon Organics Ltd. It upholds a compliant status. Employing 1 professional, Its leadership includes Sunil Mansukhlal Pitroda (Director), Ajit Annu Kamath (Director), Rajendra Padmanabhan Kaimal (Director). Past directors included Sunipa Ghosh, Krishna Tripuraneni, Shantilal Dalichand Jain. It holds ₹169.36 Cr open charges and ₹145.09 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No. 121A/1, Western Hills, Addagutta Society, Opp. Jntu, Kukatpally, India, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24110TG1993PLC016112

  • Registration Number

    016112

  • Incorporation Date

    03 August 1993

  • Authorized Capital

    ₹40.00 Cr

  • Paid-Up Capital

    ₹23.83 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Listed (BSE: 531541)

  • Company Status

    Under Cirp

Key Metrics
  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 23.83 Cr
  • Company Age 32 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 169.36 Cr
  • Satisfied Charges ₹ 145.09 Cr
  • Revenue Growth **** -8.43%
  • Profit Growth **** 63.53%
  • Ebitda **** 85.75%
  • Net Worth -4.54%
  • Total Assets -4.87%
Company report

Kobo Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kobo Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kobo Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Mansukhlal Pitroda Director 31 Mar 2018 Current
Ajit Annu Kamath Director 31 Jan 2009 Current
Rajendra Padmanabhan Kaimal Director 30 May 2013 Current
Urja Vijaykumar Shah Director 27 Dec 2018 Current
Namrata Amol Randeri Irp/Rp/Liquidator 13 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 24 Sep 2014 Past
Pramod Abcsdd Director 01 Aug 2009 Past
Pramod Abcsdd Additional Director 29 Sep 2009 Past
Pramod Abcsdd Additional Director 29 Sep 2009 Past
Pramod Abcsdd Director 22 Oct 2016 Past
Pramod Abcsdd Additional Director 25 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kobo Biotech.

Kobo Biotech Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.43% decrease. The company also saw a substantial improvement in profitability, with a 63.53% increase in profit. The company's net worth dipped by a decrease of 4.54%.

Kobo Biotech revenue growth over time
Kobo Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -8.43%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -4.87%
*******
*******
*******
*******
Profit or Loss
*******
 63.53%
*******
*******
*******
*******
Net Worth
*******
 -4.54%
*******
*******
*******
*******
EBITDA
*******
 85.75%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kobo Biotech?

In 2023, Kobo Biotech had a promoter holding of 44.95% and a public holding of 55.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,693,600,000.00

Satisfied Charges

₹1,450,908,000.00

Charges Breakdown by Lending Institutions
  • Others : 118.26 Cr
  • Indian Overseas Bank : 20.00 Cr
  • Punjab National Bank : 9.00 Cr
  • The Industrial Credit And Investment Corporation Of India Lt : 7.80 Cr
  • The Bank Of Nova Scotia : 5.00 Cr
  • Others : 9.30 Cr
Latest Charge Details
Date Lender Amount Status
29 Mar 2015 Others ₹2.00 Cr Open
11 Jan 2011 Indian Overseas Bank ₹20.00 Cr Open
10 Jul 2009 Others ₹46.76 Cr Open
29 Feb 2008 Others ₹69.50 Cr Open
13 Apr 2006 Punjab National Bank ₹9.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Kobo Biotech?

Kobo Biotech has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kobo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kobo Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kobo Biotech
Recent Activity within the Organization
  • Director Appointment

    Progress on Namrata Amol Randeri was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 13 Feb 2025 & has been associated with this company since 1 year . was documented.

  • Annual General Meeting

    Progress on Kobo Biotech Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Kobo Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge registered on 21 Mar 2003 via Charge ID 90136210 with State Bank Of India was fully satisfied on 27 Jul 2021. was recorded as a recent event.

  • Director Appointment

    Progress on Neelam Kumar Murdia was appointed as a CFO was appointed as a CFO on 14 Jun 2019 & has been associated with this company since 6 years 8 months . was documented.

  • Director Appointment

    Urja Vijaykumar Shah was appointed as a Director was appointed as a Director on 27 Dec 2018 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kobo Biotech Limited?

The CIN of Kobo Biotech Limited is L24110TG1993PLC016112.

Where is Kobo Biotech Limited headquartered?

Kobo Biotech Limited is headquartered at Plot No. 121A/1, Western Hills, Addagutta Society, Opp. Jntu, Kukatpally, India, Hyderabad, Telangana, 500072.

When was Kobo Biotech Limited incorporated?

Kobo Biotech Limited was incorporated on 03 August 1993.

Who are the current directors of Kobo Biotech Limited?

The current directors of Kobo Biotech Limited are

What is the primary industry of Kobo Biotech Limited?

The primary industry of Kobo Biotech Limited is Manufacturing.

Is Kobo Biotech Limited a listed company?

Kobo Biotech Limited is listed. It is listed on BSE: 531541.

What is the capital structure of Kobo Biotech Limited?

The authorized capital of Kobo Biotech Limited is ₹40.00 Cr, and the paid-up capital is ₹23.83 Cr.

What is the compliance status of Kobo Biotech Limited?

The compliance status of Kobo Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available